A randomized placebo-controlled trial of adefovir dipivoxil in advanced HIV infection: the ADHOC trial.
OBJECTIVES: To assess the efficacy and safety of adefovir dipivoxil (ADV) added to stable background antiretroviral therapy (ART) in HIV-infected individuals with advanced HIV disease. METHODS: ADHOC was a randomized, double-blind, placebo-controlled, international multicentre trial. Three hundred...
第一著者: | ADHOC International Steering Committee |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2002
|
類似資料
-
Adefovir dipivoxil induces DNA replication stress and augments ATR inhibitor-related cytotoxicity
著者:: Patel, A, 等
出版事項: (2020) -
Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial.
著者:: Walson, J, 等
出版事項: (2008) -
Moderate to severe HIV-associated neurocognitive impairment: A randomized placebo-controlled trial of lithium
著者:: Decloedt, E, 等
出版事項: (2016) -
The impact of immunoglobulin in acute HIV infection on the HIV reservoir: a randomized controlled trial
著者:: Tiraboschi, J, 等
出版事項: (2017) -
The impact of immunoglobulin in acute HIV infection on the HIV reservoir: a randomized controlled trial
著者:: Tiraboschi, J, 等
出版事項: (2017)